Jon D Duke

Summary

Affiliation: Regenstrief Institute
Country: USA

Publications

  1. pmc Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
    Jon D Duke
    Department of Medical Informatics, Regenstrief Institute, Indianapolis, IN 46202, USA
    J Am Med Inform Assoc 20:494-8. 2013
  2. doi request reprint Consistency in the safety labeling of bioequivalent medications
    Jon Duke
    Regenstrief Institute, Indianapolis, IN 46202, USA
    Pharmacoepidemiol Drug Saf 22:294-301. 2013
  3. pmc Data visualization speeds review of potential adverse drug events in patients on multiple medications
    Jon D Duke
    Regenstrief Institute, Indianapolis, IN, USA
    J Biomed Inform 43:326-31. 2010
  4. pmc Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions
    Jon D Duke
    Regenstrief Institute, Indianapolis, Indiana, United States of America
    PLoS Comput Biol 8:e1002614. 2012
  5. pmc A successful model and visual design for creating context-aware drug-drug interaction alerts
    Jon D Duke
    Regenstrief Institute, Indianapolis, IN, USA
    AMIA Annu Symp Proc 2011:339-48. 2011

Detail Information

Publications5

  1. pmc Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
    Jon D Duke
    Department of Medical Informatics, Regenstrief Institute, Indianapolis, IN 46202, USA
    J Am Med Inform Assoc 20:494-8. 2013
    ..We previously described a model for highlighting patients at high risk of a DDI by enhancing alerts with relevant laboratory data. We sought to evaluate the effect of this model on alert adherence in high-risk patients...
  2. doi request reprint Consistency in the safety labeling of bioequivalent medications
    Jon Duke
    Regenstrief Institute, Indianapolis, IN 46202, USA
    Pharmacoepidemiol Drug Saf 22:294-301. 2013
    ..This requirement has both clinical and legal importance, yet has never been validated. We sought to determine the real-world consistency of electronic labeling for bioequivalent drugs from different manufacturers...
  3. pmc Data visualization speeds review of potential adverse drug events in patients on multiple medications
    Jon D Duke
    Regenstrief Institute, Indianapolis, IN, USA
    J Biomed Inform 43:326-31. 2010
    ..155 s, p < 0.0001) with no decrease in accuracy. These findings suggest that information visualization can significantly expedite review of potential adverse drug events...
  4. pmc Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions
    Jon D Duke
    Regenstrief Institute, Indianapolis, Indiana, United States of America
    PLoS Comput Biol 8:e1002614. 2012
    ..This new translational biomedical informatics approach supports not only detection of new clinically significant DDI signals, but also evaluation of their potential molecular mechanisms...
  5. pmc A successful model and visual design for creating context-aware drug-drug interaction alerts
    Jon D Duke
    Regenstrief Institute, Indianapolis, IN, USA
    AMIA Annu Symp Proc 2011:339-48. 2011
    ..This framework may ultimately help reduce alert fatigue through the dynamic display of DDI alerts based on patient risk...